Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia

Expert Rev Hematol. 2017 Mar;10(3):183-185. doi: 10.1080/17474086.2017.1292121. Epub 2017 Feb 17.

Authors

Angela Maria Savino¹, Shai Izraeli²

Affiliations

¹ a Safra Children's Hospital, Sheba Medical Center, Tel Hashomer , Ramat Gan , Israel.
² b Sackler Faculty of Medicine , Tel Aviv University , Ramat Aviv , Israel.

PMID: 28162019
DOI: 10.1080/17474086.2017.1292121

No abstract available

Keywords: Acute lymphoblastic leukemia; CRLF2; JAK-STAT; TSLP; interleukin-7.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Humans
Interleukin-7 / immunology*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Signal Transduction / immunology*

Substances

IL7 protein, human
Interleukin-7